Cargando…

Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries

Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is highest and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Seale, Anna C., Hutchison, Coll, Fernandes, Silke, Stoesser, Nicole, Kelly, Helen, Lowe, Brett, Turner, Paul, Hanson, Kara, Chandler, Clare I.R., Goodman, Catherine, Stabler, Richard A., Scott, J. Anthony G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686477/
https://www.ncbi.nlm.nih.gov/pubmed/29181453
http://dx.doi.org/10.12688/wellcomeopenres.12523.1
_version_ 1783278792608841728
author Seale, Anna C.
Hutchison, Coll
Fernandes, Silke
Stoesser, Nicole
Kelly, Helen
Lowe, Brett
Turner, Paul
Hanson, Kara
Chandler, Clare I.R.
Goodman, Catherine
Stabler, Richard A.
Scott, J. Anthony G.
author_facet Seale, Anna C.
Hutchison, Coll
Fernandes, Silke
Stoesser, Nicole
Kelly, Helen
Lowe, Brett
Turner, Paul
Hanson, Kara
Chandler, Clare I.R.
Goodman, Catherine
Stabler, Richard A.
Scott, J. Anthony G.
author_sort Seale, Anna C.
collection PubMed
description Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is highest and health systems are least able to respond. This work aimed, through a combination of desk-based investigation, discussion with colleagues worldwide, and visits to three contrasting countries (Ethiopia, Malawi and Vietnam), to map and compare existing models and surveillance systems for AMR, to examine what worked and what did not work. Current capacity for AMR surveillance varies in LMICs, but and systems in development are focussed on laboratory surveillance. This approach limits understanding of AMR and the extent to which laboratory results can inform local, national and international public health policy. An integrated model, combining clinical, laboratory and demographic surveillance in sentinel sites is more informative and costs for clinical and demographic surveillance are proportionally much lower. The speed and extent to which AMR surveillance can be strengthened depends on the functioning of the health system, and the resources available. Where there is existing laboratory capacity, it may be possible to develop 5-20 sentinel sites with a long term view of establishing comprehensive surveillance; but where health systems are weaker and laboratory infrastructure less developed, available expertise and resources may limit this to 1-2 sentinel sites. Prioritising core functions, such as automated blood cultures, reduces investment at each site. Expertise to support AMR surveillance in LMICs may come from a variety of international, or national, institutions. It is important that these organisations collaborate to support the health systems on which AMR surveillance is built, as well as improving technical capacity specifically relating to AMR surveillance. Strong collaborations, and leadership, drive successful AMR surveillance systems across countries and contexts.
format Online
Article
Text
id pubmed-5686477
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-56864772017-11-27 Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries Seale, Anna C. Hutchison, Coll Fernandes, Silke Stoesser, Nicole Kelly, Helen Lowe, Brett Turner, Paul Hanson, Kara Chandler, Clare I.R. Goodman, Catherine Stabler, Richard A. Scott, J. Anthony G. Wellcome Open Res Research Article Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is highest and health systems are least able to respond. This work aimed, through a combination of desk-based investigation, discussion with colleagues worldwide, and visits to three contrasting countries (Ethiopia, Malawi and Vietnam), to map and compare existing models and surveillance systems for AMR, to examine what worked and what did not work. Current capacity for AMR surveillance varies in LMICs, but and systems in development are focussed on laboratory surveillance. This approach limits understanding of AMR and the extent to which laboratory results can inform local, national and international public health policy. An integrated model, combining clinical, laboratory and demographic surveillance in sentinel sites is more informative and costs for clinical and demographic surveillance are proportionally much lower. The speed and extent to which AMR surveillance can be strengthened depends on the functioning of the health system, and the resources available. Where there is existing laboratory capacity, it may be possible to develop 5-20 sentinel sites with a long term view of establishing comprehensive surveillance; but where health systems are weaker and laboratory infrastructure less developed, available expertise and resources may limit this to 1-2 sentinel sites. Prioritising core functions, such as automated blood cultures, reduces investment at each site. Expertise to support AMR surveillance in LMICs may come from a variety of international, or national, institutions. It is important that these organisations collaborate to support the health systems on which AMR surveillance is built, as well as improving technical capacity specifically relating to AMR surveillance. Strong collaborations, and leadership, drive successful AMR surveillance systems across countries and contexts. F1000 Research Limited 2017-09-26 /pmc/articles/PMC5686477/ /pubmed/29181453 http://dx.doi.org/10.12688/wellcomeopenres.12523.1 Text en Copyright: © 2017 Seale AC et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Seale, Anna C.
Hutchison, Coll
Fernandes, Silke
Stoesser, Nicole
Kelly, Helen
Lowe, Brett
Turner, Paul
Hanson, Kara
Chandler, Clare I.R.
Goodman, Catherine
Stabler, Richard A.
Scott, J. Anthony G.
Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title_full Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title_fullStr Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title_full_unstemmed Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title_short Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
title_sort supporting surveillance capacity for antimicrobial resistance: laboratory capacity strengthening for drug resistant infections in low and middle income countries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686477/
https://www.ncbi.nlm.nih.gov/pubmed/29181453
http://dx.doi.org/10.12688/wellcomeopenres.12523.1
work_keys_str_mv AT sealeannac supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT hutchisoncoll supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT fernandessilke supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT stoessernicole supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT kellyhelen supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT lowebrett supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT turnerpaul supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT hansonkara supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT chandlerclareir supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT goodmancatherine supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT stablerricharda supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries
AT scottjanthonyg supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries